Income Statement (TTM)
The Hydration Pharmaceuticals Company Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 | 4 | 4 | 5 | 6 | 7 | 8 | 9 | 9 | 10 | 10 | 10 | 4 | 3 | 1 | 3 | 3 | 3 |
| Change (%) | 7.31 | 6.81 | 21.15 | 17.46 | 14.95 | 13.01 | 7.16 | 6.68 | 6.44 | 6.05 | -1.13 | -57.66 | -40.73 | -68.71 | 301.76 | -4.30 | -4.50 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 2 | 2 | 1 | 2 | 1 | 1 |
| Change (%) | 7.22 | 6.73 | 10.23 | 9.28 | 9.88 | 8.99 | 5.09 | 4.84 | 9.52 | 8.69 | -5.65 | -51.46 | -35.37 | -54.72 | 125.43 | -8.00 | -8.70 | |
| % of Revenue | 64.45 | 64.39 | 64.34 | 58.55 | 54.47 | 52.07 | 50.21 | 49.24 | 48.39 | 49.79 | 51.03 | 48.69 | 55.82 | 60.87 | 88.09 | 49.43 | 47.52 | 45.43 |
| Gross Operating Profit | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 5 | 5 | 2 | 1 | 0 | 2 | 2 | 2 |
| Change (%) | 7.48 | 6.96 | 40.85 | 29.00 | 21.03 | 17.37 | 9.26 | 8.47 | 3.56 | 3.43 | 3.59 | -63.54 | -47.50 | -90.47 | 1,605.55 | -0.69 | -0.70 | |
| % of Revenue | 35.55 | 35.61 | 35.66 | 41.45 | 45.53 | 47.93 | 49.79 | 50.76 | 51.61 | 50.21 | 48.97 | 51.31 | 44.18 | 39.13 | 11.91 | 50.57 | 52.48 | 54.57 |
| SG&A | 5 | 5 | 5 | 7 | 10 | 12 | 14 | 14 | 15 | 15 | 15 | 14 | 9 | 7 | 5 | 6 | 5 | 5 |
| Change (%) | 8.28 | 7.65 | 39.47 | 28.30 | 20.62 | 17.10 | 6.66 | 6.25 | -1.80 | -1.83 | -5.76 | -37.34 | -19.69 | -24.52 | 9.51 | -6.03 | -6.42 | |
| % of Revenue | 122.76 | 123.87 | 124.84 | 143.73 | 157.00 | 164.74 | 170.70 | 169.90 | 169.21 | 156.11 | 144.50 | 137.73 | 203.80 | 276.11 | 665.98 | 181.53 | 178.25 | 174.66 |
| R&D | ||||||||||||||||||
| Change (%) | ||||||||||||||||||
| % of Revenue | ||||||||||||||||||
| OpEx | 7 | 8 | 8 | 11 | 13 | 15 | 18 | 19 | 20 | 20 | 20 | 19 | 11 | 9 | 6 | 7 | 7 | 6 |
| Change (%) | 7.80 | 7.24 | 29.44 | 22.74 | 17.84 | 15.14 | 6.31 | 5.93 | 0.72 | 0.71 | -5.73 | -41.03 | -23.06 | -29.98 | 23.05 | -6.45 | -6.90 | |
| % of Revenue | 187.84 | 188.70 | 189.45 | 202.41 | 211.52 | 216.83 | 220.91 | 219.15 | 217.60 | 205.90 | 195.53 | 186.42 | 259.62 | 336.98 | 754.07 | 230.95 | 225.76 | 220.09 |
| Operating Income | -3 | -4 | -4 | -5 | -7 | -8 | -10 | -10 | -11 | -10 | -10 | -9 | -7 | -6 | -5 | -4 | -4 | -4 |
| Change (%) | 8.36 | 7.72 | 38.70 | 27.90 | 20.42 | 16.96 | 5.60 | 5.30 | -4.15 | -4.33 | -10.55 | -21.79 | -12.00 | -13.63 | -19.56 | -8.10 | -8.81 | |
| % of Revenue | -87.84 | -88.70 | -89.45 | -102.41 | -111.52 | -116.83 | -120.91 | -119.15 | -117.60 | -105.90 | -95.53 | -86.42 | -159.62 | -236.98 | -654.07 | -130.95 | -125.76 | -120.09 |
| Interest Expense | -0 | -0 | -0 | -1 | -3 | -2 | -2 | -1 | -0 | -0 | -0 | -1 | -1 | -1 | -1 | -2 | -1 | -1 |
| Change (%) | 1,093.60 | 91.62 | 401.29 | 80.05 | -4.97 | -5.23 | -48.01 | -92.34 | 165.04 | 62.27 | 31.95 | 24.21 | 43.91 | 30.51 | 46.05 | -25.14 | -33.58 | |
| % of Revenue | -0.33 | -3.65 | -6.54 | -27.08 | -41.50 | -34.31 | -28.77 | -13.96 | -1.00 | -2.50 | -3.82 | -5.10 | -14.95 | -36.29 | -151.37 | -55.03 | -43.05 | -29.94 |
| Net Income | -1 | -2 | -4 | -6 | -9 | -10 | -11 | -11 | -11 | -10 | -10 | -9 | -8 | -8 | -8 | 3 | 4 | 4 |
| Change (%) | 219.87 | 68.74 | 61.51 | 38.08 | 11.36 | 10.20 | -1.72 | -1.75 | -3.34 | -3.45 | -9.08 | -9.98 | -2.59 | -2.66 | -134.72 | 31.36 | 23.87 | |
| % of Revenue | -19.80 | -59.01 | -93.22 | -124.27 | -146.10 | -141.53 | -138.01 | -126.57 | -116.56 | -105.85 | -96.37 | -88.62 | -188.39 | -309.60 | -963.10 | 83.23 | 114.25 | 148.19 |
Source: Capital IQ
